Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria

Autores
Ghimire, Jenisha; Hart, Robert J.; Soldano, Anabel; Chen, Charles H.; Guha, Shantanu; Hoffmann, Joseph P.; Hall, Kalen M.; Sun, Leisheng; Nelson, Benjamin J.; Lu, Timothy K.; Kolls, Jay K.; Rivera, Mario; Morici, Lisa A.; Wimley, William C.
Año de publicación
2023
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Here, we describe the continued synthetic molecular evolution of a lineage of host-compatible antimicrobial peptides (AMP) intended for the treatment of wounds infected with drug-resistant, biofilm-forming bacteria. The peptides tested are variants of an evolved AMP called d-amino acid CONsensus with Glycine Absent (d-CONGA), which has excellent antimicrobial activities in vitro and in vivo. In this newest generation of rational d-CONGA variants, we tested multiple sequence-structure-function hypotheses that had not been tested in previous generations. Many of the peptide variants have lower antibacterial activity against Gram-positive or Gram-negative pathogens, especially variants that have altered hydrophobicity, secondary structure potential, or spatial distribution of charged and hydrophobic residues. Thus, d-CONGA is generally well tuned for antimicrobial activity. However, we identified a variant, d-CONGA-Q7, with a polar glutamine inserted into the middle of the sequence, that has higher activity against both planktonic and biofilm-forming bacteria as well as lower cytotoxicity against human fibroblasts. Against clinical isolates of Klebsiella pneumoniae, innate resistance to d-CONGA was surprisingly common despite a lack of inducible resistance in Pseudomonas aeruginosa reported previously. Yet, these same isolates were susceptible to d-CONGA-Q7. d-CONGA-Q7 is much less vulnerable to AMP resistance in Gram-negative bacteria than its predecessor. Consistent with the spirit of synthetic molecular evolution, d-CONGA-Q7 achieved a critical gain-of-function and has a significantly better activity profile.
Fil: Ghimire, Jenisha. University of Tulane; Estados Unidos
Fil: Hart, Robert J.. University of Tulane; Estados Unidos
Fil: Soldano, Anabel. Louisiana Tech University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Agrobiotecnología del Litoral. Universidad Nacional del Litoral. Instituto de Agrobiotecnología del Litoral; Argentina
Fil: Chen, Charles H.. Massachusetts Institute of Technology; Estados Unidos
Fil: Guha, Shantanu. University of Tulane; Estados Unidos
Fil: Hoffmann, Joseph P.. University of Tulane; Estados Unidos
Fil: Hall, Kalen M.. University of Tulane; Estados Unidos
Fil: Sun, Leisheng. University of Tulane; Estados Unidos
Fil: Nelson, Benjamin J.. University of Tulane; Estados Unidos
Fil: Lu, Timothy K.. Massachusetts Institute of Technology; Estados Unidos
Fil: Kolls, Jay K.. University of Tulane; Estados Unidos
Fil: Rivera, Mario. State University of Louisiana; Estados Unidos
Fil: Morici, Lisa A.. University of Tulane; Estados Unidos
Fil: Wimley, William C.. University of Tulane; Estados Unidos
Materia
ANTIBIOTIC
ANTIMICROBIAL PEPTIDE
DRUG RESISTANCE
MOLECULAR EVOLUTION
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/225743

id CONICETDig_49e876939f8f4bdd9b0c46f91d7de040
oai_identifier_str oai:ri.conicet.gov.ar:11336/225743
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant BacteriaGhimire, JenishaHart, Robert J.Soldano, AnabelChen, Charles H.Guha, ShantanuHoffmann, Joseph P.Hall, Kalen M.Sun, LeishengNelson, Benjamin J.Lu, Timothy K.Kolls, Jay K.Rivera, MarioMorici, Lisa A.Wimley, William C.ANTIBIOTICANTIMICROBIAL PEPTIDEDRUG RESISTANCEMOLECULAR EVOLUTIONhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Here, we describe the continued synthetic molecular evolution of a lineage of host-compatible antimicrobial peptides (AMP) intended for the treatment of wounds infected with drug-resistant, biofilm-forming bacteria. The peptides tested are variants of an evolved AMP called d-amino acid CONsensus with Glycine Absent (d-CONGA), which has excellent antimicrobial activities in vitro and in vivo. In this newest generation of rational d-CONGA variants, we tested multiple sequence-structure-function hypotheses that had not been tested in previous generations. Many of the peptide variants have lower antibacterial activity against Gram-positive or Gram-negative pathogens, especially variants that have altered hydrophobicity, secondary structure potential, or spatial distribution of charged and hydrophobic residues. Thus, d-CONGA is generally well tuned for antimicrobial activity. However, we identified a variant, d-CONGA-Q7, with a polar glutamine inserted into the middle of the sequence, that has higher activity against both planktonic and biofilm-forming bacteria as well as lower cytotoxicity against human fibroblasts. Against clinical isolates of Klebsiella pneumoniae, innate resistance to d-CONGA was surprisingly common despite a lack of inducible resistance in Pseudomonas aeruginosa reported previously. Yet, these same isolates were susceptible to d-CONGA-Q7. d-CONGA-Q7 is much less vulnerable to AMP resistance in Gram-negative bacteria than its predecessor. Consistent with the spirit of synthetic molecular evolution, d-CONGA-Q7 achieved a critical gain-of-function and has a significantly better activity profile.Fil: Ghimire, Jenisha. University of Tulane; Estados UnidosFil: Hart, Robert J.. University of Tulane; Estados UnidosFil: Soldano, Anabel. Louisiana Tech University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Agrobiotecnología del Litoral. Universidad Nacional del Litoral. Instituto de Agrobiotecnología del Litoral; ArgentinaFil: Chen, Charles H.. Massachusetts Institute of Technology; Estados UnidosFil: Guha, Shantanu. University of Tulane; Estados UnidosFil: Hoffmann, Joseph P.. University of Tulane; Estados UnidosFil: Hall, Kalen M.. University of Tulane; Estados UnidosFil: Sun, Leisheng. University of Tulane; Estados UnidosFil: Nelson, Benjamin J.. University of Tulane; Estados UnidosFil: Lu, Timothy K.. Massachusetts Institute of Technology; Estados UnidosFil: Kolls, Jay K.. University of Tulane; Estados UnidosFil: Rivera, Mario. State University of Louisiana; Estados UnidosFil: Morici, Lisa A.. University of Tulane; Estados UnidosFil: Wimley, William C.. University of Tulane; Estados UnidosAmerican Chemical Society2023-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/225743Ghimire, Jenisha; Hart, Robert J.; Soldano, Anabel; Chen, Charles H.; Guha, Shantanu; et al.; Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria; American Chemical Society; ACS Infectious Diseases; 9; 4; 4-2023; 952-9652373-8227CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1021/acsinfecdis.2c00640info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:36Zoai:ri.conicet.gov.ar:11336/225743instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:37.027CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
title Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
spellingShingle Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
Ghimire, Jenisha
ANTIBIOTIC
ANTIMICROBIAL PEPTIDE
DRUG RESISTANCE
MOLECULAR EVOLUTION
title_short Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
title_full Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
title_fullStr Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
title_full_unstemmed Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
title_sort Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria
dc.creator.none.fl_str_mv Ghimire, Jenisha
Hart, Robert J.
Soldano, Anabel
Chen, Charles H.
Guha, Shantanu
Hoffmann, Joseph P.
Hall, Kalen M.
Sun, Leisheng
Nelson, Benjamin J.
Lu, Timothy K.
Kolls, Jay K.
Rivera, Mario
Morici, Lisa A.
Wimley, William C.
author Ghimire, Jenisha
author_facet Ghimire, Jenisha
Hart, Robert J.
Soldano, Anabel
Chen, Charles H.
Guha, Shantanu
Hoffmann, Joseph P.
Hall, Kalen M.
Sun, Leisheng
Nelson, Benjamin J.
Lu, Timothy K.
Kolls, Jay K.
Rivera, Mario
Morici, Lisa A.
Wimley, William C.
author_role author
author2 Hart, Robert J.
Soldano, Anabel
Chen, Charles H.
Guha, Shantanu
Hoffmann, Joseph P.
Hall, Kalen M.
Sun, Leisheng
Nelson, Benjamin J.
Lu, Timothy K.
Kolls, Jay K.
Rivera, Mario
Morici, Lisa A.
Wimley, William C.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ANTIBIOTIC
ANTIMICROBIAL PEPTIDE
DRUG RESISTANCE
MOLECULAR EVOLUTION
topic ANTIBIOTIC
ANTIMICROBIAL PEPTIDE
DRUG RESISTANCE
MOLECULAR EVOLUTION
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Here, we describe the continued synthetic molecular evolution of a lineage of host-compatible antimicrobial peptides (AMP) intended for the treatment of wounds infected with drug-resistant, biofilm-forming bacteria. The peptides tested are variants of an evolved AMP called d-amino acid CONsensus with Glycine Absent (d-CONGA), which has excellent antimicrobial activities in vitro and in vivo. In this newest generation of rational d-CONGA variants, we tested multiple sequence-structure-function hypotheses that had not been tested in previous generations. Many of the peptide variants have lower antibacterial activity against Gram-positive or Gram-negative pathogens, especially variants that have altered hydrophobicity, secondary structure potential, or spatial distribution of charged and hydrophobic residues. Thus, d-CONGA is generally well tuned for antimicrobial activity. However, we identified a variant, d-CONGA-Q7, with a polar glutamine inserted into the middle of the sequence, that has higher activity against both planktonic and biofilm-forming bacteria as well as lower cytotoxicity against human fibroblasts. Against clinical isolates of Klebsiella pneumoniae, innate resistance to d-CONGA was surprisingly common despite a lack of inducible resistance in Pseudomonas aeruginosa reported previously. Yet, these same isolates were susceptible to d-CONGA-Q7. d-CONGA-Q7 is much less vulnerable to AMP resistance in Gram-negative bacteria than its predecessor. Consistent with the spirit of synthetic molecular evolution, d-CONGA-Q7 achieved a critical gain-of-function and has a significantly better activity profile.
Fil: Ghimire, Jenisha. University of Tulane; Estados Unidos
Fil: Hart, Robert J.. University of Tulane; Estados Unidos
Fil: Soldano, Anabel. Louisiana Tech University; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Agrobiotecnología del Litoral. Universidad Nacional del Litoral. Instituto de Agrobiotecnología del Litoral; Argentina
Fil: Chen, Charles H.. Massachusetts Institute of Technology; Estados Unidos
Fil: Guha, Shantanu. University of Tulane; Estados Unidos
Fil: Hoffmann, Joseph P.. University of Tulane; Estados Unidos
Fil: Hall, Kalen M.. University of Tulane; Estados Unidos
Fil: Sun, Leisheng. University of Tulane; Estados Unidos
Fil: Nelson, Benjamin J.. University of Tulane; Estados Unidos
Fil: Lu, Timothy K.. Massachusetts Institute of Technology; Estados Unidos
Fil: Kolls, Jay K.. University of Tulane; Estados Unidos
Fil: Rivera, Mario. State University of Louisiana; Estados Unidos
Fil: Morici, Lisa A.. University of Tulane; Estados Unidos
Fil: Wimley, William C.. University of Tulane; Estados Unidos
description Here, we describe the continued synthetic molecular evolution of a lineage of host-compatible antimicrobial peptides (AMP) intended for the treatment of wounds infected with drug-resistant, biofilm-forming bacteria. The peptides tested are variants of an evolved AMP called d-amino acid CONsensus with Glycine Absent (d-CONGA), which has excellent antimicrobial activities in vitro and in vivo. In this newest generation of rational d-CONGA variants, we tested multiple sequence-structure-function hypotheses that had not been tested in previous generations. Many of the peptide variants have lower antibacterial activity against Gram-positive or Gram-negative pathogens, especially variants that have altered hydrophobicity, secondary structure potential, or spatial distribution of charged and hydrophobic residues. Thus, d-CONGA is generally well tuned for antimicrobial activity. However, we identified a variant, d-CONGA-Q7, with a polar glutamine inserted into the middle of the sequence, that has higher activity against both planktonic and biofilm-forming bacteria as well as lower cytotoxicity against human fibroblasts. Against clinical isolates of Klebsiella pneumoniae, innate resistance to d-CONGA was surprisingly common despite a lack of inducible resistance in Pseudomonas aeruginosa reported previously. Yet, these same isolates were susceptible to d-CONGA-Q7. d-CONGA-Q7 is much less vulnerable to AMP resistance in Gram-negative bacteria than its predecessor. Consistent with the spirit of synthetic molecular evolution, d-CONGA-Q7 achieved a critical gain-of-function and has a significantly better activity profile.
publishDate 2023
dc.date.none.fl_str_mv 2023-04
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/225743
Ghimire, Jenisha; Hart, Robert J.; Soldano, Anabel; Chen, Charles H.; Guha, Shantanu; et al.; Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria; American Chemical Society; ACS Infectious Diseases; 9; 4; 4-2023; 952-965
2373-8227
CONICET Digital
CONICET
url http://hdl.handle.net/11336/225743
identifier_str_mv Ghimire, Jenisha; Hart, Robert J.; Soldano, Anabel; Chen, Charles H.; Guha, Shantanu; et al.; Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-Resistant Bacteria; American Chemical Society; ACS Infectious Diseases; 9; 4; 4-2023; 952-965
2373-8227
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1021/acsinfecdis.2c00640
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Chemical Society
publisher.none.fl_str_mv American Chemical Society
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842270164867874816
score 13.13397